-
1.发明申请公开(公告)号：US20210403592A1
公开(公告)日：2021-12-30
申请号：US17329057
申请日：2021-05-24
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , C07K16/40 , A61K39/395 , A61K38/47 , A61K45/06 , A61K31/454 , A61K31/573
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
-
2.发明申请Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD28-Positive Hematological Malignancies 审中-公开用于治疗轻链淀粉样变性和其他CD28阳性血液恶性肿瘤的抗CD38抗体公开(公告)号：US20170008966A1
公开(公告)日：2017-01-12
申请号：US15160476
申请日：2016-05-20
Applicant: Janssen Biotech, Inc. , Tufts Medical Center, Inc.
Inventor： Chakra Chaulagain , Raymond Comenzo , Parul Doshi , Xun Ma , Amy Sasser
IPC: C07K16/28 , A61K45/06 , A61K38/05 , A61K31/664 , A61K31/573 , A61K9/00 , A61K38/47 , A61K39/395 , A61K31/69
Abstract: The present invention relates to methods of treatment of light chain amyloidosis and other CD38-positive hematological malignancies with anti-CD38 antibodies.
Abstract translation: 本发明涉及用抗CD38抗体治疗轻链淀粉样变性和其它CD38阳性血液恶性肿瘤的方法。
-
公开(公告)号：US11618787B2
公开(公告)日：2023-04-04
申请号：US16177239
申请日：2018-10-31
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Christopher Chiu , Ming Qi , Amy Sasser , Jordan Schecter
IPC: C07K16/28 , A61K39/395 , A61P35/00 , A61K31/573 , A61K31/495 , A61K31/4439 , A61K31/69 , A61K9/00 , A61K31/454 , A61K39/00
Abstract: Disclosed are methods of treating a subject having high-risk multiple myeloma, methods of achieving negative minimal residual disease status in a subject having multiple myeloma, and methods of predicting a likelihood of, or decreasing a risk of, relapse and/or disease progression in a subject having multiple myeloma.
-
公开(公告)号：US10793630B2
公开(公告)日：2020-10-06
申请号：US14956890
申请日：2015-12-02
Applicant: Janssen Biotech, Inc.
Inventor： Parul Doshi , Gwenn Danet-Desnoyers , Cedric Dos Santos , Amy Sasser , Xiaochuan Shan
IPC: A61K39/00 , C07K16/28 , A61K39/395 , A61K31/704 , A61K31/706 , A61K31/7068 , A61K45/06 , A61N5/10
Abstract: The present invention relates to methods of treatment of acute myeloid leukemia with anti-CD38 antibodies.
-
公开(公告)号：US10766965B2
公开(公告)日：2020-09-08
申请号：US15160476
申请日：2016-05-20
Applicant: Janssen Biotech, Inc. , Tufts Medical Center, Inc.
Inventor： Chakra Chaulagain , Raymond Comenzo , Parul Doshi , Xun Ma , Amy Sasser
IPC: C07K16/28 , A61K39/395 , A61K9/00 , A61K31/573 , A61K31/664 , A61K31/69 , A61K38/05 , A61K38/47 , A61K45/06 , A61K39/00
Abstract: The present invention relates to methods of treatment of light chain amyloidosis and other CD38-positive hematological malignancies with anti-CD38 antibodies.
-
Patent Agency Ranking
公开(公告)号：US12091466B2
公开(公告)日：2024-09-17
申请号：US16986214
申请日：2020-08-05
Applicant: Janssen Biotech, Inc. , Tufts Medical Center, Inc.
Inventor： Chakra Chaulagain , Raymond Comenzo , Parul Doshi , Xun Ma , Amy Sasser
IPC: C07K16/28 , A61K9/00 , A61K31/573 , A61K31/664 , A61K31/69 , A61K38/05 , A61K38/47 , A61K39/395 , A61K45/06 , A61K39/00
CPC classification number: C07K16/2896 , A61K9/0019 , A61K31/573 , A61K31/664 , A61K31/69 , A61K38/05 , A61K38/47 , A61K39/3955 , A61K45/06 , C12Y302/01035 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732
Abstract: The present invention relates to methods of treatment of light chain amyloidosis and other CD38-positive hematological malignancies with anti-CD38 antibodies.
-
7.发明申请公开(公告)号：US20190144557A1
公开(公告)日：2019-05-16
申请号：US16162355
申请日：2018-10-16
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , A61K39/395 , A61K45/06 , A61K31/454 , A61K31/573 , A61K38/47 , C07K16/40
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
-
公开(公告)号：US20190127479A1
公开(公告)日：2019-05-02
申请号：US16177239
申请日：2018-10-31
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Christopher Chiu , Ming Qi , Amy Sasser , Jordan Schecter
IPC: C07K16/28 , A61P35/00 , A61K31/573 , A61K31/4439 , A61K31/69 , A61K9/00 , A61K39/395
Abstract: Disclosed are methods of treating a subject having high-risk multiple myeloma, methods of achieving negative minimal residual disease status in a subject having multiple myeloma, and methods of predicting a likelihood of, or decreasing a risk of, relapse and/or disease progression in a subject having multiple myeloma.
-
9.发明申请公开(公告)号：US20250066501A1
公开(公告)日：2025-02-27
申请号：US18825958
申请日：2024-09-05
Applicant: Janssen Biotech, Inc.
Inventor： Tahamtan Ahmadi , Tineke Casneuf , Henk Lokhorst , Tuna Mutis , Amy Sasser , Niels van de Donk
IPC: C07K16/28 , A61K31/454 , A61K31/573 , A61K38/47 , A61K39/00 , A61K39/395 , A61K45/06 , C07K16/40
Abstract: The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
-
公开(公告)号：US20210047401A1
公开(公告)日：2021-02-18
申请号：US17005039
申请日：2020-08-27
Applicant: Janssen Biotech, Inc.
Inventor： Parul Doshi , Gwenn Danet-Desnoyers , Cedric Dos Santos , Amy Sasser , Xiaochuan Shan
IPC: C07K16/28 , A61K39/395 , A61K31/704 , A61K31/706 , A61K31/7068 , A61K45/06 , A61N5/10
Abstract: The present invention relates to methods of treatment of acute myeloid leukemia with anti-CD38 antibodies.
-
-
-
-
-
-
-
-
-
Search Results
16
records
(took 0.016 seconds)
